HQH insider buying and SEC filings, explained
abrdn Healthcare Investors · CIK 805267
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$11K
Insiders who bought
1
Sold (not marked 10b5-1)
$5K
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Oct 6, 2026 | Sale | Alan R Goodson (Director) sold 242 shares at $19.32 ($5K). Holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Oct 7, 2026, 12:57 PM ET |
| Jul 16, 2026 | Purchase (code P) | Chris LaVictoire Mahai (Director) bought 501 shares at $20.96 ($11K), reported as a purchase (code P). New position of 501 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 20, 2026 |
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow HQH in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.